BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32988908)

  • 1. Clinical Efficacy of Tumor Treating Fields for Newly Diagnosed Glioblastoma.
    Liu Y; Strawderman MS; Warren KT; Richardson M; Serventi JN; Mohile NA; Milano MT; Walter KA
    Anticancer Res; 2020 Oct; 40(10):5801-5806. PubMed ID: 32988908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interventional effect of new drugs combined with the Stupp protocol on glioblastoma: A network meta-analysis.
    Li M; Song X; Zhu J; Fu A; Li J; Chen T
    Clin Neurol Neurosurg; 2017 Aug; 159():6-12. PubMed ID: 28514722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme.
    Athanassiou H; Synodinou M; Maragoudakis E; Paraskevaidis M; Verigos C; Misailidou D; Antonadou D; Saris G; Beroukas K; Karageorgis P
    J Clin Oncol; 2005 Apr; 23(10):2372-7. PubMed ID: 15800329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Super-early initiation of temozolomide prolongs the survival of glioblastoma patients without gross-total resection: a retrospective cohort study.
    Jiang H; Zeng W; Ren X; Cui Y; Li M; Yang K; Elbaroody M; Lin S
    J Neurooncol; 2019 Aug; 144(1):127-135. PubMed ID: 31175579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
    Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
    Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility evaluation of hypofractionated radiotherapy with concurrent temozolomide in elderly patients with glioblastoma.
    Uto M; Mizowaki T; Ogura K; Arakawa Y; Mineharu Y; Miyamoto S; Hiraoka M
    Int J Clin Oncol; 2016 Dec; 21(6):1023-1029. PubMed ID: 27384182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor treating fields and maintenance temozolomide for newly-diagnosed glioblastoma: a cost-effectiveness study.
    Guzauskas GF; Pollom EL; Stieber VW; Wang BCM; Garrison LP
    J Med Econ; 2019 Oct; 22(10):1006-1013. PubMed ID: 31050315
    [No Abstract]   [Full Text] [Related]  

  • 8. Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status.
    Brandes AA; Franceschi E; Tosoni A; Benevento F; Scopece L; Mazzocchi V; Bacci A; Agati R; Calbucci F; Ermani M
    Cancer; 2009 Aug; 115(15):3512-8. PubMed ID: 19514084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor treating fields: a novel and effective therapy for glioblastoma: mechanism, efficacy, safety and future perspectives.
    Zhu P; Zhu JJ
    Chin Clin Oncol; 2017 Aug; 6(4):41. PubMed ID: 28841803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Survival Analysis with Identification of Prognostic Factors in a Series of 110 Patients with Newly Diagnosed Glioblastoma Before and After Introduction of the Stupp Regimen: A Single-Center Observational Study.
    Illic R; Somma T; Savic D; Frio F; Milicevic M; Solari D; Nikitovic M; Lavrnic S; Raicevic S; Milosevic S; Cavallo LM; Cappabianca P; Grujicic D
    World Neurosurg; 2017 Aug; 104():581-588. PubMed ID: 28522381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfasalazine and temozolomide with radiation therapy for newly diagnosed glioblastoma.
    Takeuchi S; Wada K; Nagatani K; Otani N; Osada H; Nawashiro H
    Neurol India; 2014; 62(1):42-7. PubMed ID: 24608453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advantages and Disadvantages of Combined Chemotherapy with Carmustine Wafer and Bevacizumab in Patients with Newly Diagnosed Glioblastoma: A Single-Institutional Experience.
    Akiyama Y; Kimura Y; Enatsu R; Mikami T; Wanibuchi M; Mikuni N
    World Neurosurg; 2018 May; 113():e508-e514. PubMed ID: 29476996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved survival of Swedish glioblastoma patients treated according to Stupp.
    Bruhn H; Strandéus M; Milos P; Hallbeck M; Vrethem M; Lind J
    Acta Neurol Scand; 2018 Oct; 138(4):332-337. PubMed ID: 29882211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical correlates of severe thrombocytopenia from temozolomide in glioblastoma patients.
    Arulananda S; Lynam J; Sem Liew M; Wada M; Cher L; Gan HK
    Intern Med J; 2018 Oct; 48(10):1206-1214. PubMed ID: 29923272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial.
    Gállego Pérez-Larraya J; Ducray F; Chinot O; Catry-Thomas I; Taillandier L; Guillamo JS; Campello C; Monjour A; Cartalat-Carel S; Barrie M; Huchet A; Beauchesne P; Matta M; Mokhtari K; Tanguy ML; Honnorat J; Delattre JY
    J Clin Oncol; 2011 Aug; 29(22):3050-5. PubMed ID: 21709196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience.
    Jeon HJ; Kong DS; Park KB; Lee JI; Park K; Kim JH; Kim ST; Lim DH; Kim WS; Nam DH
    Clin Neurol Neurosurg; 2009 Oct; 111(8):679-82. PubMed ID: 19640635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity and survival in primary glioblastoma patients treated with concomitant plus adjuvant temozolomide versus adjuvant temozolomide: results of a single-institution, retrospective, matched-pair analysis.
    Gutenberg A; Bock HC; Reifenberger G; Brück W; Giese A
    Acta Neurochir (Wien); 2013 Mar; 155(3):429-35. PubMed ID: 23254891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide.
    Stupp R; Dietrich PY; Ostermann Kraljevic S; Pica A; Maillard I; Maeder P; Meuli R; Janzer R; Pizzolato G; Miralbell R; Porchet F; Regli L; de Tribolet N; Mirimanoff RO; Leyvraz S
    J Clin Oncol; 2002 Mar; 20(5):1375-82. PubMed ID: 11870182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma.
    Stupp R; Hegi ME; Neyns B; Goldbrunner R; Schlegel U; Clement PM; Grabenbauer GG; Ochsenbein AF; Simon M; Dietrich PY; Pietsch T; Hicking C; Tonn JC; Diserens AC; Pica A; Hermisson M; Krueger S; Picard M; Weller M
    J Clin Oncol; 2010 Jun; 28(16):2712-8. PubMed ID: 20439646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encouraging experience of concomitant Temozolomide with radiotherapy followed by adjuvant Temozolomide in newly diagnosed glioblastoma multiforme: single institution experience.
    Jalali R; Basu A; Gupta T; Munshi A; Menon H; Sarin R; Goel A
    Br J Neurosurg; 2007 Dec; 21(6):583-7. PubMed ID: 18071985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.